a three-fold increase in the risk of blood clots for drospirenone-containing products
San Diego, CA (PRWEB) January 04, 2013
AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Yasmin and Yaz lawsuits.
According to court documents, on December 11th, 2012, five plaintiffs filed a lawsuit in Illinois Southern District Court (case no. 3:2012cv11630) alleging they suffered serious medical issues from their use of Yasmin and Yaz. Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. Yasmin and Yaz are manufactured by Bayer Healthcare Pharmaceuticals.
In the lawsuit, the estate of a woman alleges she died after having a stroke having taken Yasmin or Yaz for slightly over a month. Another plaintiff claims she developed severe complications with her gallbladder from her use of the drugs that required its removal. The other three plaintiffs claim they suffer from deep vein thrombosis (DVT), blood clots and heart blockage caused by Yasmin and Yaz.
As Bloomberg BusinessWeek reported on July 31st, 2012, Bayer set aside €496 million for settlement costs from lawsuits over Yasmin and Yaz from women claiming the drugs caused blood clots that led to serious health consequences.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Yasmin severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Yasmin lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
On April 10, 2012, FDA updated the drug labels for drospirenone-containing birth control pills, including Yasmin and Yaz. The new labels report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins.
AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/1/prweb10282762.htm.